SHARE:

< Back to Search

Neurology® Podcast - July 8 2014 Issue

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

1) Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease and 2) Topic of the month: Plenary sessions AAN Meeting April 2014. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Mytinger interviews Dr. Russell Dale about his paper on utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Dr. James Addington is reading our e-Pearl of the week about pseudo-internuclear ophthalmoplegia. In the next part of the podcast Dr. Alber Read More

Download this Episode

Episode Segments

Introduction (00:17 - 00:55)
00:17 00:55

Play Segment

Interview-Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease (00:56 - 09:51)
ePearl 1-pseudo-internuclear ophthalmoplegia (09:52 - 11:35)
LOTW-Robert Wartenberg Lecture at the AAN Meeting about Alzheimer's disease in 2014: Mapping a road forward (11:36 - 20:57)
11:36 20:57

Play Segment

MeSH Terms
ePearl 2-pseudo-internuclear ophthalmoplegia (20:58 - 22:08)
Closing (22:09 - 24:14)
22:09 24:14

Play Segment

Log On

MEMBER LOG IN

Forgot password?